Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Abt, 2016, Prostatic artery embolization vs conventional TUR-P in the treatment of benign prostatic hyperplasia: first results of a prospective, randomized non-inferiority trial, European Urology Supplement, 15, e1080, 10.1016/S1569-9056(16)61081-3

Abt, 2018, Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial, BMJ, 361, k2338, 10.1136/bmj.k2338

Abt, 2021, Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial, European Urology, 80, 34, 10.1016/j.eururo.2021.02.008

Abt, 2014, Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial, BMC Urology, 14, 94, 10.1186/1471-2490-14-94

Abt, 2021, Prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: two-year outcomes of a randomised, open label, single-centre trial, European Urology, 79, S83, 10.1016/S0302-2838(21)00449-8

Müllhaupt, 2020, Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials, World Journal of Urology, 38, 2595, 10.1007/s00345-019-03036-7

Prostatic artery embolization vs. conventional transurethral prostatectomy in the treatment of benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT02054013

Database for the assessment of efficacy and safety of BPH treatment clinicaltrials.gov/show/NCT03521648

Carnevale FC Iscaife A Yoshinaga EM Moreira AM Antunes AA Srougi M Transurethral resection of the prostate (TURP) versus original and perfected prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis Cardiovascular and Interventional Radiology 2016 39 1 44 52 10.1007/s00270-015-1202-4

Yoshinaga EM Nakano E Marchini GS Galvao O Baroni R Carnevale FC A prospective and randomized trial comparing transurethral resection of the prostate (TURP) to prostate artery embolization (PAE) for treatment of bladder outlet obstruction due to benign prostatic hyperplasia (BPH) Journal of Urology 2014 191 4 Suppl e793 10.1016/j.juro.2014.02.2168

Gao Y Huang Y Zhang R Yang YD Zhang Q Hou M Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate - a prospective, randomized, and controlled clinical trial Radiology 2014 270 3 920 8 10.1148/radiol.13122803

Capdevila, 2021, Prostatic artery embolization versus transurethral resection of the prostate: a post hoc cost analysis of a randomized controlled clinical trial, Cardiovascular and Interventional Radiology, 44, 1771, 10.1007/s00270-021-02920-3

Giral Villalta PJ Aguilar Guevara JF Lopez Ubillos G Lacarra Fernandez S Zabalo San Juan A Asiáin Urmeneta M Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: 12 month results of a clinical trial European Urology, Supplements 2019 18 1 e1494 5 10.1016/S1569-9056(19)31075-9

Insausti I Sáez de Ocáriz García A Galbete A Capdevila F Solchaga S Giral P Randomized comparison of prostatic arterial embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia Journal of Vascular and Interventional Radiology 2020 31 6 882 90 10.1016/j.jvir.2019.12.810

Napal Lecumberri, 2018, Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial, Research and Reports in Urology, 10, 17, 10.2147/RRU.S139086

Clinical trial to evaluate the efficacy and safety of the transarterial supraselective embolization of the prostate to treat the urinary symptoms clinicaltrials.gov/ct2/show/NCT01963312

Saez De Ocariz Garcia, 2017, Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: 6-month results of a clinical trial, Cardiovascular and Interventional Radiology, 40, S117

Clinical trial of prostatic arterial embolization versus a sham procedure to treat benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT02074644

Pisco, 2020, Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia, European Urology, 77, 354, 10.1016/j.eururo.2019.11.010

Radwan A Farouk A Higazy A Samir YR Tawfeek AM Gamal MA Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia Prostate International 2020 8 3 130 3 10.1016/j.prnil.2020.04.001

Dasgupta, 2018, Prostate artery embolisation versus TURP; a multicentric prospective comparison: the UK-ROPE study, Journal of Urology, 199, e835, 10.1016/j.juro.2018.02.2010

Modi, 2016, UK-ROPE: preliminary findings, Cardiovascular and Interventional Radiology, 39, S152

UK ROPE Register Study clinicaltrials.gov/show/NCT02434575

ROPE registry project to determine the safety and efficacy of prostate artery embolisation (PAE) for lower urinary tract symptoms secondary to benign prostatic enlargement (LUTS BPE) clinicaltrials.gov/show/NCT02849522

Ray, 2018, Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study), BJU International, 122, 270, 10.1111/bju.14249

Soluyanov, 2018, First experience with prostate artery embolization for benign prostatic hyperplasia, Urologia, 4, 33, 10.18565/urology.2018.4.33-37

Zhu, 2018, Prostate artery embolization and transurethral resection of prostate for benign prostatic hyperplasia: a prospective randomized controlled trial, Chinese Journal of Interventional Imaging and Therapy, 15, 134, 10.13929/j.1672-8475.201711043

Abt, 2019, Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial, BJU International, 124, 134, 10.1111/bju.14632

Bagla, 2017, Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia, Cardiovascular and Interventional Radiology, 40, 1694, 10.1007/s00270-017-1700-7

Bagla, 2016, Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia, Journal of Vascular and Interventional Radiology, 27, S56, 10.1016/j.jvir.2015.12.154

Bilhim, 2015, Prostatic arterial embolization versus transurethral resection of the prostate for benign prostatic hyperplasia, Radiology, 276, 310, 10.1148/radiol.2015141853

Brown AD Stella SF Simons ME Minimally invasive treatment for benign prostatic hyperplasia: economic evaluation from a standardized hospital case costing system Cardiovascular and Interventional Radiology 2019 42 4 520 7 10.1007/s00270-018-2132-8

Mullhaupt, 2019, In-hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial, BJU International, 123, 1055, 10.1111/bju.14660

Prostatic artery embolization for benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT01835860

Prostatic artery embolization versus 532 nm green light PVP for catheterized patients clinicaltrials.gov/ct2/show/NCT02006303

Prospective controlled randomized study of PAE vs TURP for BPH treatment clinicaltrials.gov/ct2/show/NCT02566551

Innovative minimally invasive options in treatment of urinary problems related to prostate enlargement (BPH) in men clinicaltrials.gov/show/NCT03043222

Pereira K Ford-Glanton S Johar R Xu P Pham K Gadani S Prostatic artery embolization (PAE) and prostatic urethral lift (PUL) procedures for symptomatic benign prostatic enlargement (BPH): a retrospective, single-center comparison of outcomes Journal of Vascular and Interventional Radiology 2018 29 4 Suppl 1 S6 10.1016/j.jvir.2018.01.010

Qiu, 2017, Clinical evaluation of embolization of the superior vesical prostatic artery for treatment of benign prostatic hyperplasia: a single-center retrospective study, Wideochir Inne Tech Maloinwazyjne, 12, 409, 10.5114/wiitm.2017.72324

Russo, 2015, Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities, Urology, 86, 343, 10.1016/j.urology.2015.04.037

Russo, 2015, Prostatic arterial embolization vs open prostatectomy: a matched-pair analysis of functional outcomes and morbidities after 1 year of follow-up, European Urology Supplement, 14, e570, 10.1016/S1569-9056(15)60563-2

Steurer, 2018, Benign prostatic hyperplasia: transurethral resection or embolization of prostate arteries?, Praxis, 107, 1115, 10.1024/1661-8157/a003068

Wu, 2019, Interventional embolization vs transurethral resection for the treatment of benign prostatic hyperplasia in elderly patients: a comparison study, Journal of Interventional Radiology, 28, 179

Ng, 2020, Comparison of prostatic artery embolisation with transurethral resection of the prostate for high-risk surgical candidates in obstructive uropathy or refractory retention: a prospective cohort study, International Journal of Urology, 27, 113

Prostate artery embolization for patients with lower urinary tract symptoms due to benign prostate hyperplasia anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373427

Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia www.chictr.org.cn/com/25/showprojen.aspx?proj=25226

Prostate artery embolization with embosphere microspheres compared to TURP for benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT01789840

Artery embolization vs operation of benign prostate hyperplasia (NORTAPE) clinicaltrials.gov/ct2/show/NCT04084938

Prostate artery embolization compared to holmium laser enucleation of the prostate for benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT04236687

PROARTE -PROstate ARTery to reduce the symptoms of benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT04807010

Ahyai, 2010, Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement, European Urology, 58, 384, 10.1016/j.eururo.2010.06.005

Barry, 1995, Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?, Journal of Urology, 154, 1770, 10.1016/S0022-5347(01)66780-6

Barry, 1997, The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists, Journal of Urology, 157, 10, 10.1016/S0022-5347(01)65267-4

Bhatia, 2018, Prostate artery embolization in patients with prostate volumes of 80 mL or more: a single-institution retrospective experience of 93 patients, Journal of Vascular and Interventional Radiology, 29, 1392, 10.1016/j.jvir.2018.05.012

Bhojani, 2014, Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program, Journal of Endourology, 28, 831, 10.1089/end.2013.0805

Brasure, 2016, Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: a Review

Carnevale, 2010, Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients, Cardiovascular and Interventional Radiology, 33, 355, 10.1007/s00270-009-9727-z

Centers for Disease Control and Prevention, 2003, Public health and aging: trends in aging - United States and worldwide, JAMA, 289, 1371, 10.1001/jama.289.11.1371

Chapple C Castro-Diaz D Chuang YC Lee KS Liao L Liu SP Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study Advances in Therapy 2017 34 8 1953 65

Veritas Health Innovation Covidence 2013

Deeks JJ Higgins JP Altman DG Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org/handbook/archive/v5.1/

DeMeritt, 2000, Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization, Journal of Vascular and Interventional Radiology, 11, 767, 10.1016/S1051-0443(07)61638-8

Dindo, 2004, Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey, Annals of Surgery, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Dunphy, 2015, Relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia, Reviews in Urology, 17, 51

European Association of Urology Management of non-neurogenic male LUTS uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/

Egan, 2016, The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates, Urologic Clinics of North America, 43, 289, 10.1016/j.ucl.2016.04.001

EndNote Clarivate Analytics 2016

Feinsten L Matlaga B Urologic diseases in America US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office, 2018; NIH Publication No. 12-7865

Feng, 2017, Prostatic arterial embolization treating moderate-to-severe lower urinary tract symptoms related to benign prostate hyperplasia: a meta-analysis, Cardiovascular and Interventional Radiology, 40, 22, 10.1007/s00270-016-1516-x

McMaster University (developed by Evidence Prime) GRADEpro GDT 2015

Guyatt, 2008, GRADE: what is "quality of evidence" and why is it important to clinicians?, BMJ (Clinical Research Ed), 336, 995, 10.1136/bmj.39490.551019.BE

Guyatt, 2011, GRADE guidelines 6. Rating the quality of evidence - imprecision, Journal of Clinical Epidemiology, 64, 1283, 10.1016/j.jclinepi.2011.01.012

Guyatt, 2011, GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables, Journal of Clinical Epidemiology, 64, 383, 10.1016/j.jclinepi.2010.04.026

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, 21, 1539, 10.1002/sim.1186

Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ (Clinical Research Ed), 327, 557, 10.1136/bmj.327.7414.557

Higgins JP Altman DG Sterne JA Chapter 8. Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org/handbook/archive/v5.1/

Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org/handbook/archive/v6

Johnston, 2010, Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units, Health and Quality of Life Outcomes, 8, 116, 10.1186/1477-7525-8-116

Jung, 2019, Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012832.pub2

Kang, 2020, Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD013251.pub2

Kuang, 2017, A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia, Cardiovascular and Interventional Radiology, 40, 655, 10.1007/s00270-016-1539-3

Lerner, 2021, Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I - initial work-up and medical management, Journal of Urology, 206, 806, 10.1097/JU.0000000000002183

Lerner, 2021, Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II - surgical evaluation and treatment, Journal of Urology, 206, 818, 10.1097/JU.0000000000002184

Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Medicine, 6, e1000100, 10.1371/journal.pmed.1000100

Malaeb, 2012, National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008), Urology, 79, 1111, 10.1016/j.urology.2011.11.084

Malling, 2019, Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis, European Radiology, 29, 287

Martin, 2014, Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men, Journal of Urology, 191, 130, 10.1016/j.juro.2013.06.018

Martins Pisco, 2012, How to perform prostatic arterial embolization, Techniques in Vascular and Interventional Radiology, 15, 286, 10.1053/j.tvir.2012.09.002

McVary, 2018, Three-year outcomes of the prospective, randomized controlled Rezūm System study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, Urology, 111, 1, 10.1016/j.urology.2017.10.023

McWilliams, 2019, Society of Interventional Radiology multisociety consensus position statement on prostatic artery embolization for treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia: from the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology, Journal of Vascular and Interventional Radiology, 30, 627, 10.1016/j.jvir.2019.02.013

Mitchell, 1976, Control of massive prostatic bleeding with angiographic techniques, Journal of Urology, 115, 692, 10.1016/S0022-5347(17)59339-8

Narayan, 2017, Re: efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression: SR Shim, KJ Kanhai, YM Ko, JH Kim. Journal of Urology 2017;197:465-79, Journal of Urology, 198, 215, 10.1016/j.juro.2017.02.3337

National Institute for Health and Care Excellence Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. Interventional procedures guidance www.nice.org.uk/guidance/ipg611

Nickel, 2015, Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia - integrated data from 1,499 study participants, BJU International, 115, 815, 10.1111/bju.12926

Omar, 2014, Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP), BJU International, 113, 24, 10.1111/bju.12281

Pariser, 2015, National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes, Urology, 86, 721, 10.1016/j.urology.2015.06.048

Parsons, 2015, A national, comparative analysis of perioperative outcomes of open and minimally invasive simple prostatectomy, Journal of Endourology, 29, 919, 10.1089/end.2014.0879

Pisco, 2016, Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients, Journal of Vascular and Interventional Radiology, 27, 1115, 10.1016/j.jvir.2016.04.001

Pyo, 2017, Systematic review and meta-analysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia, Clinical Radiology, 72, 16, 10.1016/j.crad.2016.10.009

Rees, 2015, Patients not P values, BJU international, 115, 678, 10.1111/bju.12994

Reich, 2008, Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients, Journal of Urology, 180, 246, 10.1016/j.juro.2008.03.058

Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014

Roehrborn, 2008, Pathology of benign prostatic hyperplasia, International Journal of Impotence Research, 20 Suppl 3, S11, 10.1038/ijir.2008.55

Roehrborn, 2017, Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study, Canadian Journal of Urology, 24, 8802

Rosen, 1997, The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0

Rosen, 2007, Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction, Urology, 69, 805, 10.1016/j.urology.2007.02.036

Schünemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11. Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org/handbook/archive/v5.1/

Schünemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12. Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org/handbook/archive/v5.1/

Schünemann, 2013, Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions, Research Synthesis Methods, 4, 49, 10.1002/jrsm.1078

Schünemann HJ Cuello C Akl EA Mustafa RA Meerpohl JJ Thayer K GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence Journal of Clinical Epidemiology 2019 111 105 14

Shim, 2017, Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression, Journal of Urology, 197, 465, 10.1016/j.juro.2016.08.100

Spaliviero, 2010, Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function?, Journal of Endourology, 24, 2051, 10.1089/end.2010.0296

Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355, i4919, 10.1136/bmj.i4919

Sterne JA Higgins JP Elbers RG Reeves BC Development group for ROBINS-I Risk of bias In non-randomized studies of interventions (ROBINS-I): detailed guidance, updated 12 October 2016 www.riskofbias.info

Sun, 2008, Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment - preliminary study in pigs, Radiology, 246, 783, 10.1148/radiol.2463070647

Taub, 2006, The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States, Current Urology Reports, 7, 272, 10.1007/s11934-996-0006-0

Wang, 2015, Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (> 80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population, BMC Urology, 15, 33, 10.1186/s12894-015-0026-5

World Health Organization Proposed working definition of an older person in Africa for the MDS project www.who.int/healthinfo/survey/ageingdefnolder/en

Xu, 2020, An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia, World Journal of Urology, 38, 2069, 10.1007/s00345-019-02954-w

Yoo, 2012, Benign prostatic hyperplasia: from bench to clinic, Korean Journal of Urology, 53, 139, 10.4111/kju.2012.53.3.139

Young, 2017, Prostate arterial embolization is a viable option for treating symptoms of benign prostatic hyperplasia: pro, Journal of Urology, 198, 9, 10.1016/j.juro.2017.04.073

Zlotta, 1997, Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study, Journal of Urology, 157, 894, 10.1016/S0022-5347(01)65077-8

Zumstein V Betschart P Vetterlein MW Kluth LA Hechelhammer L Mordasini L Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis European Urology Focus 2019 5 6 1091 100

Jung, 2017, Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012867

Jung, 2020, Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012867.pub2